Team 5 Merck Final - 2
Team 5 Merck Final - 2
Team 5 Merck Final - 2
Analysis
Vishaal Patil
Jonathan Florez
Saisarath Buddhavarapu
Harsh Rohan Sistla
Originally Angel Pharmacy, Merck & Co., Inc. has built a good
reputation through over a century of activity
1668 - Acquired by apothecary Jacob Fredrick Merck
d.b.a.Merck Sharp & Dohme(MSD) outside the United States and Canada,
Headquarters Kenilworth, NJ
1891
George Merck emigrated to the United States and established Merck & Co.
partner E. Merck (nowMerck KGaA)
1917
US government intervention forced the company to cease & desist in
accordance with a confiscation due to wartime policy
1945
End of WWII the year that George W. Merck concluded his company leadership
Today
Merck & Co. hold the rights to the name in North America, while its former
parent company retains the rights in the rest of the world.
Acquisitions
6/2014: Acquisition of Idenix Pharma
12/2014
$8.4 billion acquisition of buy Cubist Pharma announced
Swiss Biotech OncoEthix acquistion
Vitamin B1 discovery
Measles vaccine creation
Cold remedies
Antacids
Cholesterol treatments
Animal health items
In line with their core values, for humans who eventually consume
meat from these animals, Merck provides farms the opportunity to
ensure quality animal products
This is also aligned with general life improvement and scientific
excellence in diverse fields
Merck Manuals
A series of reference books for various medical professionals
Merck Manual of Diagnosis and Therapy is the world's best-selling medical
reference
2012 - Highly respected and competent complications lead to acquisition of The
Merck Index by theRoyal Society of Chemistry
Core Values
Monsato Vioxx
Mercks disadvantage and late response led to a loss
Marketing
Unique marketing through cross-functional teams allows for early
development processes
Alliances
Timely R&D investment
Brand Name Reputation
Strong and leading financial position as a top firm in the
industry
Diversification
Market expansion
Mercks management is really strong with its idea of
investing a large sum of money on research with its idea
that in the coming years it would benefit them a lot with
the ease of taking stand in the market has proved to be
more than beneficial.
Weaknesses
Weaknesses
Opportunities
Opportunities
Threats
Threats
A strong brand
name in the
pharmaceutical
industry
Huge products
portfolio in
pharmaceutical
industry
Provides medical
help to
underprivileged
people
Excellent R&D
and innovations
Has international
presence
Brand visibility
Problems of fake
imitations affects
the company
Hasnt been able
to aggressively
enter emerging
economies
Broad-based
medical
innovation
Venture into
health needs in
underdeveloped
countries
Leverage its core
business
expertise and
resources to
create
sustainable
solutions in
countries around
the world.
Increase
obsolesce of
technology
Competition from
peers
NSAID (Non-Steroid
Anti-Inflammatory
Drug.
FDA Approved for
chronic and acute pain
associated with
Arthritis and similar
conditions.
Withdrawn 5 years
after approved.
Profits declined
after withdrawal
of Vioxx.
Competitor
profits largely
unaffected.
Code of Conduct
Integrity
Respect
Transparency
Courage
Achievement
Responsibility
Code of Conduct
The Details
Office of Ethics
Ethics
12/7/2012 Merck foundation ended donations to theBoy Scouts of Americabecause of "its policy that
excludes members on the basis of sexual orientation", which "directly conflicts with the Merck Foundation's
giving guidelines.
Economic Impact
Impacts
Portfolios
PVI 25 Companies
Focused on US Companies
MSV 23 Companies
Budgets
PVI - $10M per company, $50M per year
MSV controls three separate funds
MSV Fund $108,542,500
Joint ventures, mergers, etc.
References: